Clinical Trials List
2023-03-27 - 2029-07-30
Phase II
Not yet recruiting5
Recruiting1
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 王逸熙 Division of Thoracic Medicine
- 張育平 Division of Thoracic Medicine
- Chia-Cheng Tseng Division of Thoracic Medicine
- 鍾聿修 Division of Thoracic Medicine
- 林理涵 Division of Thoracic Medicine
- 陳彥豪 Division of Thoracic Medicine
- 賴建豪 Division of Thoracic Medicine
- 陳怡豪 Division of Thoracic Medicine
- Shau-Hsuan Li Division of Thoracic Medicine
- 張晃智 Division of Thoracic Medicine
- 黃國棟 Division of Thoracic Medicine
- 林孟志 Division of Thoracic Medicine
- 陳友木 Division of Thoracic Medicine
- 趙東瀛 Division of Thoracic Medicine
- 李易濰 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 李和昇 Division of Thoracic Medicine
- Ming-Shyan Huang Division of Thoracic Medicine
- 許棨逵 Division of Thoracic Medicine
- 周柏安 Division of Thoracic Medicine
- 謝坤洲 Division of Thoracic Medicine
- 邱建通 Division of Thoracic Medicine
- 陳鍾岳 Division of Thoracic Medicine
- 陳靜宜 Division of Thoracic Medicine
- 吳俊廷 Division of Thoracic Medicine
- 陳俊榮 Division of Thoracic Medicine
- 高明蔚 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 李柏昕 Division of Thoracic Medicine
- YEN-HSIANG HUANG Division of Thoracic Medicine
- KUO-HSUAN HSU Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
17 participants
-
Global
180 participants